Industry Insights

  1. Conquer Study Start-Up Delays With A Data-Driven Approach

    Study start-up delays have perplexed the best minds in the clinical trials industry for decades. Discover how advanced analytics and an intense focus on the four problem areas can help.

  2. A Proactive Approach To Ebola Vaccine Development

    Best practices for rapid test development and regulatory approvals.

  3. Study Stakeholder Collaboration Takes The Stage At DIA

    A strategy to reduce potential conflicts when working with clinical research study stakeholders.

  4. Fighting Cancer: Biomarkers For Immuno-Oncology Clinical Trials

    Using anatomic pathology for biomarker development in clinical trials can help predict and assess how a patient will respond to immuno-oncology therapies

  5. DIA Panel Preview: Thinking Pragmatically About The Future Of Real World Evidence

    Questions and concerns as the FDA prepares to develop and implement a program evaluating the potential use of Real World Evidence (RWE) for regulatory decisions.

  6. Three Things eClinical Providers Owe Their Users

    Three essential things for data managers to look for - and for technology providers like us to deliver - as clinical trial technology becomes more prevalent and diverse.

  7. Immunotherapy And PD-L1: The Future Of Precision Medicine

    Advances in precision medicine lead to new trends in immunotherapy.

  8. Using Advanced Techniques For Protein Bioanalysis

    Overcoming hurdles in a regulated setting.

  9. Five Considerations For Sites Preparing For eConsent

    Five areas to investigate to determine whether your site is ready based on the 2016 FDA-OHRP guidance about eConsents.

  10. Subject Recruitment Materials: Understanding The Requirements For IRB Review

    A breakdown of regulatory guidances and a clear picture of what the IRB needs to see.